Researchers conducted a retrospective cohort study of incident healthcare–associated CDI cases to determine the association between continuous PPI use and CDI recurrence within 90 days.
The cohort consisted of 754 patients who developed CDI. The study found the cause-specific hazard ratios for recurrence were 1.5 for patients older than 75 years, 1.5 for patients with continuous PPI use, 1.003 per day for length of stay and 1.3 for antibiotic re-exposure. The use of PPIs was common, with only 47.1 percent of patients having an evidence-based indication.
More articles on GI/endoscopy:
Mount Sinai Beth Israel names Dr. Ira Jacobson department of medicine chairman
Baylor St. Luke’s Medical Center acquires SpyGlass technology
AGA names inaugural class of Future Leaders Program
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.